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ABSTRACT Lanreotide, a synthetic, therapeutic octapeptide analog of somatostatin, self-assembles in water into perfectly
hollow and monodisperse (24-nm wide) nanotubes. Lanreotide is a cyclic octapeptide that contains three aromatic residues. The
molecular packing of the peptide in the walls of a nanotube has recently been characterized, indicating four hierarchical levels of
organization. This is a fascinating example of spontaneous self-organization, very similar to the formation of the gas vesiclewalls of
Halobacterium halobium. However, this unique peptide self-assembly raises important questions about its molecular origin. We
adopted a directed mutation approach to determine the molecular parameters driving the formation of such a remarkable peptide
architecture. We havemodiﬁed the conformation by opening the cycle and by changing the conformation of a Lys residue, and we
have also mutated the aromatic side chains of the peptide. We show that three parameters are essential for the formation of
lanreotide nanotubes: i), the speciﬁcity of two of the three aromatic side chains, ii), the spatial arrangement of the hydrophilic and
hydrophobic residues, and iii), the aromatic side chain in the b-turn of the molecule. When these molecular characteristics are
modiﬁed, either the peptides lose their self-assembling capability or they form less-ordered architectures, such as amyloid ﬁbers
and curved lamellae. Thus we have determined key elements of the molecular origins of lanreotide nanotube formation.
INTRODUCTION
Self-assembly is characterized by spontaneous diffusion and
specific association of molecules dictated by noncovalent
interactions. It can be biologically inspired given that the cells
contain numerous functional nanostructures built from mo-
lecular self-assembly, such as membranes, actin filaments,
tubules, chromosomes, flagella, and cytoskeleton. But self-
association processes are also essential during biological
processes such as protein folding, molecular recognition, and
enzyme-substrate binding.
The key elements of molecular self-assembly are a com-
plementary shape between the individual components and
weak noncovalent interactions. For biologicalmaterials, these
noncovalent interactions are typically hydrogen bonds (intra-
and intermolecular andwithwater), ionic bonds, hydrophobic
effects, and electrostatic and van der Waals interactions. Al-
though many of these interactions are weak (,5 kcal/mol),
their large numbers make the final architectures highly stable.
Another consequence of these types of interactions is the
possibility of rapid exchange between a molecule involved
in the architecture and an external molecule in solution. This
implies that the self-assemblies have dynamic properties and
a kind of ‘‘self-repair’’ faculty. Therefore, central to mim-
icking biologically inspired self-assembly is the understand-
ing of the forces that govern the thermodynamic stability and
specificity of naturally occurring self-assembly. The emer-
gence of amyloid-related diseases has further increased sci-
entific interest in this field (1–4). Moreover, the possibility of
creating nanomaterials of controlled size by using biomimetic
molecules has extended the appeal to other scientific fields,
especially physics and chemistry (5–9).
In this respect, synthetic small molecules like peptides and/
or lipids with self-assembling properties are explored exten-
sively because of their simplicity, which offers the prospect of
understanding the molecular mechanisms driving the self-
assembly processes. The bioinspired strategy for the design of
simple self-assembling peptides is mainly applied in the de
novo synthesis of peptides. For example, Ghadiri’s group has
explored the self-assembling properties of cyclic synthetic
peptides forming nanotubes of molecular dimensions through
molecular stacking mediated by unidirectional hydrogen
bonds (10–12). A second hierarchical level of organization
can be induced by generating self-assemblies between the
one-dimensional nanotubes, leading finally to bundles of nano-
tubes. Another remarkable example is the polar lipid mim-
icking peptides designed by Zhang et al. (13). These lipid-like
peptides self-assemble into architectures usually adopted by
polar lipids like nanotubes and/or vesicular structures, under-
lining the importance of amphiphilicity in molecular packing.
Because of the emergence of prion-related diseases, peo-
ple are also working extensively on the molecular processes
that drive the formation of a special type of architecture
formed by the self-assembly of misfolded proteins, generally
called ‘‘amyloid’’ fibers. The term ‘‘amyloid’’, meaning
‘‘starch-like’’, was originally applied by mistake to extracellular
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protein aggregates found in the organs of patients suffering from
amylose, because these aggregates were stained by iodine as is
starch (14). Later, it was discovered that amyloids were in
fact protein precipitates constituted by ordered fiber/filament
structures, which were stabilized by extended intermolecular
b-sheet (15). In this article we apply the term ‘‘amyloid’’ to
fibers, filaments, and even nanotubes structures when they
are proved to be stabilized by an intermolecular b-sheet
network.
Not only prion proteins but also various natural peptides
and proteins have been shown to self-assemble in vitro into
amyloid-like b-sheet-rich supramolecular fibrils (4,16–18),
leading to the idea that the amyloid state is a common feature
of proteins (20). In addition, recent studies point out the
involvement of such self-assembled amyloid fibrils in the
formation of biofilm and aerial hyphae by microorganisms
(21–23), underlining the importance of these particular supra-
molecular architectures. Whatever the protein studied, the
inner supramolecular structure of amyloids relies on inter-
molecular b-sheet hydrogen-bond networks along the fibril
director, the so-called ‘‘cross-b’’ organization (24). At the
molecular level,pp interactions have been proposed to play
a significant role in the nucleation process (25) and in the
cohesion of characteristic amyloid fibers (26,27).
Themajor difficulty in understanding the precisemolecular
organization of amyloid fibers stems from the common fea-
ture shared by these supramolecular architectures: they are not
three-dimensional crystals but rather disordered precipitates/
aggregates of intrinsically ordered fibers. This disorder gen-
erates difficulties in establishing the detailed molecular orga-
nization. To overcome this problem and to gain detailed
information on the molecular interactions involved in the
mechanisms of formation of prion amyloid fibers, numerous
studies have been performed on peptides extracted from the
sequence of native prion proteins that retain self-assembly
properties (28–32). Even crystals of amyloid fibers have re-
cently been obtained, allowing the resolution of the precise
molecular organization of the amyloid peptide studied (3).
Vale´ry et al. (33,34) have recently shown that the cyclic
octapeptide lanreotide self-associates into nanotubes in the
presence of water. Lanreotide (Fig. 1 a; DNal-Cys-Tyr-
DTrp-Lys-Val-Cys-Thr-CONH2) is a synthetic therapeutic
FIGURE 1 Chemical structure of lanreotide (a) and its derivatives named Cys-Ala and Lan-b-M (b), Lys-DLys (c), DTrp-DPhe (d), Tyr-Phe (e), and DNal-
DPhe (f). The numbers 1–8 on the peptide backbone of lanreotide indicate the positions of the amino acids. All the peptides contain 2 mol of acetate per mole of
peptide, the acetate being the counterion of the two positive charges of the peptides.
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peptide used mainly in the treatment of acromegaly (35). The
most remarkable features of these nanotubes are their mono-
disperse diameter (24 nm) and their relatively large size when
compared to the size of the peptide. Thanks to this exceptional
monodispersity, the peptide packing in these self-assemblies
has been determined (34). This packing exhibits as many as
four hierarchical levels of organization, which are, from the
lowest to the highest, 1), dimers of peptides essentially sta-
bilized by hydrophobic effects and aromatic side-chain in-
teraction; 2), amyloid filaments generated by the packing
of peptide dimers through an intermolecular antiparallel
b-sheet network between the peptide backbones, i.e., a typ-
ical ‘‘cross-b’’ organization; 3), nanotubes generated by the
lateral packing of 26 filaments, in which the H-bond network
lies flat on the nanotube surface; and 4), the packing of the
nanotubes in a hexagonal lattice. The temperature/concen-
tration phase diagram of lanreotide has also been determined
and indicates that the nanotubes are at thermodynamic equi-
librium and reversible (33).
Such a detailed description of the molecular and supra-
molecular organization is unique in the field of synthetic
biomimetic assembly. This hierarchical peptide organiza-
tion, completely new and not previously described for pep-
tide self-assemblies, is very similar to the organization of the
hydrophobic proteins forming the wall of the gas vesicles of
Halobacterium halobium (36,37). Indeed, both the lanreo-
tide nanotubes and the gas vesicles walls are bilayers formed
by the lateral assembly of fibers formed by two protofila-
ments. Moreover, as for lanreotide, the peptide skeleton and
therefore the H-bond networks lie flat on the surfaces of the
walls. However, this type of organization is very rare even in
nature. In general, self-assemblies such as amyloid-type fi-
bers present only two hierarchical levels of organization, i.e.,
the one-dimensional packing of the protein/peptide mediated
by intermolecular b-sheet, leading to twisted fibrils, and the
fibril assembly into the final fibers, called lamination by Aggeli
et al. (38). For this type of aggregate, it is also possible to see a
few examples of hollow tubular morphology of amyloid fibers
(32,39,40). Nevertheless, the exceptionally ordered lanreo-
tide self-assembly immediately raises the question of the mo-
lecular parameters driving this organization.
In this work, we have adopted a mutational approach to test
the role of different molecular parameters in the organization
of self-assembly structures such as the b-hairpin conforma-
tion and the aromatic residue.
Lanreotide adopts a b-hairpin conformation in organic
solvents (41,42), a conformation that is stabilized for the
peptide self-assembled in nanotubes (33,34). There are at least
two molecular parameters stabilizing this conformation: i),
the succession ofD andL amino acids at positions 4 and 5, i.e.,
D-Trp followed by L-Lys, inducing a turn in the peptide
backbone; and ii), the presence of the two cysteines that form a
disulfide bridge in a gauche-gauche-gauche (g-g-g) confor-
mation (Fig. 1 a). To test the role of the molecular con-
formation in lanreotide packing, we studied three derivatives,
i.e., Lys-DLys inwhich the conformation of the lysine residue
has been modified, the Cys-Ala in which the two Cys have
been replaced by two Ala, and the Lan-b-M obtained by
treatment of lanreotide with b-mercaptoethanol to obtain
two free sulfhydryl (SH) groups instead of the initial disulfide
bond (Fig. 1, b and c).
Lanreotide also possesses three aromatic residues
(D-naphthylalanine, tyrosine, and D-tryptophan) that are all
segregated on one branch of the b-hairpin (Fig. 1 a). In our
previous work we showed that this aromatic-aliphatic
segregation is enhanced in the supramolecular architectures
at each of the four hierarchical levels of organization, thus
demonstrating the involvement of the aromatic residues in
lanreotide self-assembly. In this work, we mutated each of
these aromatic side chains into another aromatic residue,
i.e., Phe, to test the specificity of the aromatic side chains of
lanreotide. Three derivatives are tested here in which we
successively substituted the DTrp, the LTyr, and the DNal
aromatic groups by Phe in accordance with the conforma-
tion in the lanreotide molecule.
The study was performed using infrared and Raman spec-
troscopies to determine the conformations of the molecules,
small angle x-ray scattering (SAXS) and wide angle x-ray
scattering (WAXS) to obtain structural information on the self-
assemblies, and optical and electron microscopy to character-
ize the morphology of the structures formed.
MATERIALS AND METHODS
Materials
In Fig. 1, the lanreotidemolecule has been drawn togetherwith the derivatives
synthesized for this study. Lanreotide (NH13 -DNal-Cys-Tyr-DTrp-Lys-Val-
Cys-Thr-CONH2) and its derivatives were obtained from Ipsen-Pharma
(Barcelona, Spain) as acetate salts. The names and formulae of the derivatives
are Cys-Ala (NH13 -DNal-Ala-Tyr-DTrp-Lys-Val-Ala-Thr-CONH2), Lys-
DLys (NH13 -DNal-Cys-Tyr-DTrp-DLys-Val-Cys-Thr-CONH2), DTrp-DPhe
(NH13 -DNal-Cys-Tyr-DPhe-Lys-Val-Cys-Thr-CONH2), Tyr-Phe (NH
1
3 -DNal-
Cys-Phe-DTrp-Lys-Val-Cys-Thr-CONH2), and DNal-DPhe (NH13 -DPhe-Cys-
Tyr-DTrp-Lys-Val-Cys-Thr-CONH2). The peptides were synthesized by a
Kinerton batch process (Dublin, Ireland), which includes a flash-freeze
lyophilization. Also, 99.9% glycerol, 99% solid naphthalene, and 14 M
b-mercaptoethanol were from Sigma (Paris, France).
Sample preparation
Lanreotide acetate aqueous solutions up to 10% w/w and all the solutions of
derivative peptides were prepared by adding deionized water to a weighted
fraction of lanreotide acetate powder. For peptide concentrations higher than
10% w/w, the viscosity of the mixtures required the application of a special
mixing technique. The system used consisted of two plastic syringes of 2 ml
connected by a small tap. One syringe was filled with a weighted fraction of
peptide powder, and the other was filled with a weighted fraction of water.
The syringe containing the peptide was connected to the tap and a vacuum
was produced with a water pump. The other syringe was then connected to
the tap and the mixture realized by passing the dispersion from one syringe
to the other until total homogenization. The samples were generally prepared
24 h before the experiments and stored at 4C. For the Lys-DLys derivative,
the samples were examined at different times after preparation.
1784 Vale´ry et al.
Biophysical Journal 94(5) 1782–1795
Optical microscopy
Optical microscopy experiments were realized at room temperature (;20C)
with crossed polarizers (or phase contrast) using a type 120 Nikon micro-
scope equipped with a Nikon 20 objective (Nikon, Tokyo, Japan). The pho-
tographs were obtained with a Nikon Coolpix 950 digital camera. The samples
observed were conditioned either in 1.3 mm glass capillaries or between glass
slices.
Small angle x-ray scattering
X-ray patternswere collectedwith aMar345 Image-Plate detector (Maresearch,
Norderstedt, Germany) mounted on a rotating anode x-ray generator FR591
(Bruker, Courtaboeuf, France) operated at 50 kV and 50 mA. The mono-
chromatic CuKa radiation (l ¼ 1.541 A˚) was focused with a 350 mm focal
spot at 320 mm by a double reflection on a elliptic cross multilayer Montel
mirror (Incoatec, Geesthacht, Germany). The beam was defined under vac-
uum by four motorized carbon-tungsten slits (JJ-Xray, Roskilde, Denmark)
positioned in front of the mirror (500 mm). Four additional guard slits (600
mm)were placed at the focal pointwith a 220mmslit separation. Theflux after
the output mica windows was 33 108 photons/s. A 2-mm diameter circular
lead beam stop was placed in air at 150 mm after the sample, and the detector
was positioned at 360 mm. The x-ray patterns were therefore recorded for a
range of reciprocal spacing q ¼ 4p sinu/l (with u the scattering angle) from
0.03 to 1.8 A˚1, i.e., a range of repetitive distances d¼ 2p/q from200 A˚ to 3.5
A˚. The samples were put in 1.2–1.3 mm glass capillaries (Glas Technik and
Konstruktion, Scho¨newalde bei Berlin, Germany) and introduced into a
homemade capillary holder accommodating 20 capillaries at controlled
temperature or subject to a computer-monitored controlled temperature
program.
For the Trp-Phe samples, SAXS was performed on the high brilliance
ID2A beam line of the European Synchrotron Radiation Facility (ESRF,
Grenoble, France) using sample-detector distances of 1.5–6.5 m depending
on the experiments. The diffraction patterns were therefore recorded for
reciprocal spacing q (A˚1) from 0.02 to 0.5 A˚1, i.e., a range of repetitive
distances d ¼ 2p/q from 310 A˚ and 12 A˚. The samples were put in 1.2–1.3
mm glass capillaries and introduced into the homemade holder. The x-ray
patterns were detected and recorded via a chip charge-coupled device
camera detector. All samples exhibited powder diffraction and the scattering
intensities as a function of the radial wave vector, q ¼ 4p sinu/l was deter-
mined by circular integration (43).
Freeze-fracture electron microscopy
and negative staining
For freeze-fracture electron microscopy, samples were prepared in a solution
containing 30% glycerol. As a preliminary, SAXS patterns were recorded
for the peptide solutions in the absence and presence of glycerol; all showed
that the molecular and supramolecular packing of the peptide was not af-
fected by the glycerol. The only difference observed in some cases was a shift
toward higher concentration in the critical concentration of self-assembly.
Droplets of samples were deposited on copper holders for double replica and
frozen in LN2-cooled cryofreeze (L4194, Agar scientific, Stansted, UK).
Freeze-fracturing of the double replica sandwiches was done in a Balzers
BAF 300 freeze-fracture apparatus (BAL-TEC, Balzers, Liechtenstein)
under 107 Torr vacuum, and a platinum replica of the fracture face was
shadowed on fractured samples at an incidence of 45 followed by a carbon
replica at 90. Metallic replicas were floated on water and collected on
copper electron microscope (EM) grids for observation under the electron
microscope.
For the DTrp-DPhe derivative, the freeze-fracture was performed in the
absence of glycerol. Drops of DTrp-DPhe solution were sandwiched be-
tween two copper platelets using a 400 mesh gold grid as spacer. The
samples were then frozen at 180C by rapid immersion in liquid propane
and stored at 196C in liquid nitrogen until subsequent use. Frozen
samples were fractured at150C and 23 107 mbar in a Balzers BAF 300
freeze-fracture apparatus. Freeze-etching was carried out by switching the
sample temperature from 150C to 100C and maintaining the pressure
at 107 mbar for 2 min to sublimate the surface layer of ice. Metal replicas of
the exposed surfaces were obtained by evaporating 2 nm of platinum with an
electron gun at an angle of 45 and 20 nm of carbon with an electron gun at
an angle of 90.
For negative staining, samples were prepared in water and deposited
directly on formvar-coated nickel EM grids. After 1 min, the grids were
blotted on filter work and dried. Then, samples were negatively stained with
a drop of 2% uranyl acetate in water, blotted, and dried on filter work again.
EM grids (from freeze-fracture or negative staining) were observed either
in a Philips 400 (FEI company, Eindhoven, The Netherlands) transmission
electron microscope and photographed on Kodak SO-163 negative films
(Kodak, Rochester, NY) or were examined with a JEOL 1010 transmission
electron microscope (JEOL, Tokyo, Japan) at 80 kV.
Fourier transform infrared spectroscopy
Attenuated total reflectance (ATR) Fourier transform infrared spectroscopy
(FTIR) spectra were measured at 4 cm1 resolution with a Bruker IFS 66
spectrophotometer equipped with a 45 n ZnSe ATR attachment. The
spectra shown resulted from the average of 50 scans. Spectra were corrected
for the linear dependence on the wavelength of the absorption measured by
ATR. The water signal was removed by subtraction of a pure water spectrum
recorded the day of the experiment. Analysis of the lanreotide conformation
was performed by decomposition of the absorption spectra, either as a sum
of Gaussian components (44) or as a sum of spectra assigned to different
structures (45).
Fourier transform and Raman spectroscopy
Fourier transform (FT)-Raman spectra were recorded at 4 cm1 resolution
using a Bruker IFS 66 interferometer coupled to a Bruker FRA 106 Raman
module equipped with a continuous neodymium-doped yttrium aluminum
garnet laser providing excitation at 1064 nm, as described in Mattioli et al.
(43). All spectra were recorded at room temperature with backscattering
geometry from concentrated samples (.10% w/w of lanreotide acetate) held
in standard aluminum cups. The spectra resulted from 100 to 1000 coadded
interferograms depending on the sample signal.
RESULTS
Conformational mutants: Cys-Ala, Lan-b-M,
and Lys-DLys
Samples were prepared by mixing the derivatives up to 10%
(w/w) with deionized water. Macroscopically, the three pep-
tides form gels from concentrations around 2–3% (w/w). These
gels all show birefringence under polarized light, indicating the
formation of supramolecular architectures (data not shown).
However, developable surfaces could be detected in none of
these gels, as previously observed for lanreotide gels. This
indicates that the gels formed by the derivatives contain more
rigid structures than the lanreotide nanotubes. At concentra-
tions above 10% (w/w), the lysine derivative peptide be-
comes partly insoluble and precipitates.
The peptide backbone conformation and hydrogen-bond-
ing patterns were probed by FTIR (focusing on the amide
I band). The disulfide bridge conformation was probed by
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FT-Raman spectroscopy (Fig. 2). The FT-Raman spectra
recorded for solutions of Lan-b-M and Cys-Ala derivatives
(Fig. 2 a) show the disappearance of the vibrational mode at
509 cm1 when compared with the spectrum of lanreotide.
The S-S bond stretching vibration depends on the confor-
mation of the C-S-S-C group (46). In particular it can exhibit
three different vibration wave numbers, i.e., 509, 523, and
540 cm1, which have been respectively assigned to g-g-g,
t-g-g, and g-t-g conformations. The strong vibration at 520
cm1 recorded on both the Lan-b-M and Cys-Ala spectra
(Fig. 2 a, traces 4 and 6) and on the Lys-DLys spectrum (Fig.
2 c) can be attributed to a naphthalene vibrational mode, as
previously done for the lanreotide spectra (33). Although the
Raman spectra of pure naphthalene, either solid or dissolved
in tetrahydrofuran (THF), exhibit a slightly shifted mode, i.e.,
515 and 511 cm1, respectively (Fig. 2 a, traces 1 and 2), the
attribution of this vibration to the naphthyl group is further
supported by the spectrum obtained for a derivative lacking
the naphthyl group (see trace 3, see Fig. 7 a). The shift of this
vibration when compared with pure naphthalene is due to the
covalent bond between the naphthyl cycle and the b-carbon
atom of the naphthylalanine residue (data not shown). On the
other hand, the vibration at 540 cm1 disappears for peptides
lacking the tryptophan residue (see Fig. 7 a, trace 1). The
509 cm1 vibration can be attributed to a g-g-g conformation
of the disulfide bridge. On both spectra of Lan-b-M and Cys-
Ala derivatives, the loss of this sharp vibration indicates the
loss of the disulfide bond. The asymmetric aspect of the
naphthyl vibration band of the Lan-b-M sample is due to the
presence of b-mercaptoethanol, as shown by its correspond-
ing FT-Raman spectra (trace 3, Fig. 2).
The FTIR spectra recorded for lanreotide solutions before
and after reduction of the disulfide bridge are plotted in Fig. 2
b (traces 1, 2, 19, and 29). Upon reduction by b-mercapto-
ethanol, the absorptions characteristic of the backbone car-
bonyl groups involved in H-bonds in turn and in random
conformation (absorptions at 1660 and 1640 cm1, respec-
tively) almost completely disappear (Fig. 2 c, traces 19 and
29). Moreover, for Lan-b-M as for Cys-Ala (Fig. 2 b, trace 3)
the resulting amide I vibration absorption spectra exclusively
show two maxima at 1625 and 1685 cm1. The presence and
position of these two maxima have been described as
characteristic of H-bonds in an antiparallel b-sheet confor-
mation (47,48). The peptide FTIR global spectra are
composed by the superposition of the spectra of the non-
assembled peptide and of the assembled one, the contribu-
tion of the nonassembled one decreasing with concentration.
To access the number of backbone carbonyls involved in
such an antiparallel b-sheet network, we decomposed the
FTIR spectra obtained for the highest peptide concentration
into individual components (Fig. 2 and Table1). From this
decomposition, the area of the two peaks at 1625 and 1685
cm1 represent between 82% and 87% of the total area of the
amide I bands, which gives, when compared with the total
number of backbone carbonyls, ;7 backbone carbonyls
involved in the antiparallel b-sheet network for both Cys-Ala
and Lan-b-M derivatives. Taking the Raman and FTIR
observations together, we can conclude that both Lan-b-M
and the Cys-Ala derivative adopt a linear conformation. We
also can deduce that the extended b-sheet network is formed
between the linear peptides packed head-to-tail within the
assemblies.
FIGURE 2 FT-Raman (a and c) and ATR-FTIR (b and
d) spectra. (a) FT-Raman spectra (l ¼ 1064 nm) of
naphthalene powder (trace 1), naphthalene in THF (trace
2), b-mercaptoethanol (b-M) 1 M (trace 3), Lan-b-M 20%
w/w in water (trace 4), lanreotide acetate 20% w/w in
water (trace 5), and Cys-Ala acetate 15% w/w in water
(trace 6). Dashed arrows indicate the position of the
vibrations of disulfide bridge in a g-g-g conformation (505
cm1), the naphthalene group in the peptide (520 cm1),
and tryptophan (545–550 cm1). (b) ATR-FTIR spectra of
the amide I band of lanreotide acetate 5% and 10% w/w in
water (traces 1 and 2, respectively) and of Lan-b-M
acetate 5% and 10% w/w (traces 19 and 29, respectively).
ATR-FTIR spectra of Cys-Ala acetate 10% w/w in water
(trace 3) together with the decomposition into individual
components (thin line peaks under the spectrum; see Table
2 for more details). Arrows indicate the position of the
absorption peaks associated with the carbonyl involved in
H-bonds in intermolecular b-sheet (1625 and 1685 cm1),
random coil (1640 cm1), and turn (1660 cm1) confor-
mations. (c) FT-Raman spectra (l ¼ 1064 nm) of Lys-
DLys acetate 15% w/w in water. For arrow definitions, see
legend panel a. (d) ATR-FTIR spectra of Lys-DLys acetate
5% w/w (traces 1 and 19) and 10%w/w (traces 2 and 29) in
water. The spectra were recorded either just after the
dilution of the peptide in water (traces 1 and 2) or 24 h
after the dilution (19 and 29).
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Like lanreotide, the S-S bond of the Lys-DLys derivative
can be detected in the FT-Raman spectrum (Fig. 2 c) by a
well-defined stretching vibration band at 509 cm1, charac-
teristic of a g-g-g conformation. The FTIR time-dependent
spectra of the Lys-DLys amide I vibration (Fig. 2 d) recorded
after dissolution of the peptide in water changed from a
broad to a more structured spectrum. This indicates that the
peptide backbone undergoes slow conformational changes
that are probably related to slow kinetics of self-assembly.
The FTIR spectrum recorded 24 h after mixing consists of a
combination of b-sheet and random and turn conformations
with an overall broader shape than the lanreotide spectrum
(Fig. 2 b).
Negative staining and/or freeze-fracture electron micro-
graphs of Lan-b-M, Cys-Ala, and Lys-DLys samples are
shown in Figs. 3–5, respectively. Reduction (Lan-b-M, Fig.
3) or deletion (Cys-Ala, Fig. 4) of the disulfide bridge leads
to the formation of tubular structures that are wider (diameter
range: 100–200 nm) and shorter (lengths ,1 mm) than the
lanreotide nanotubes. On the electron micrographs of Lan-
b-M, twisted ribbons coexist with wide nanotubes (Fig. 3).
As the twisted ribbons have diameters similar to the tubes, it
can be assumed that they are structural intermediates of the
final tubes. For the Cys-Ala derivative, such twisted ribbon
intermediates were not visualized. The freeze-fracture pic-
tures of the Cys-Ala derivative show sections of uni- or
multilayered tubes (Fig. 4, a and b). Diameter analysis shows
a high polydispersity for both the Cys-Ala and the Lan-b-M
structures. However, the average diameter of the Lan-b-M
tubes or ribbons is smaller (100 nm) than that of the Cys-Ala
tubes (200 nm).
The Lys-DLys derivative forms typical amyloid-like fibers
(Fig. 5, a and b) with a thickness ranging from 7 to 13 nm (Fig.
5 c) and with shorter lengths (up to 1 mm) than the lanreotide
nanotubes. From these electron micrographs, we cannot dis-
tinguish between ribbon-like fibers and small hollow tubes.
The pictures in Fig. 5, a and b, of negatively stained 10%Lys-
DLys solutions were taken just after the preparation of the
solution and after a few days of equilibration, respectively.
They show the slow self-assembly process as seen in the time-
dependent changes of the FTIR spectra.
Fig. 6 shows the WAXS patterns obtained for Lan-b-M
(Fig. 6 a) and the Cys-Ala (Fig. 6 b) and Lys-DLys (Fig. 6 c)
derivatives. In Fig. 6 a, the WAXS patterns obtained for in-
creasing concentrations of Lan-b-M show the same scatter-
ing peaks. Moreover, the WAXS patterns for both Lan-b-M
and Cys-Ala derivatives show similar Bragg reflections (Fig.
3). This indicates that the two peptides adopt the same molec-
ular packing within the corresponding architectures. Con-
sidering the large nanotubes or curved lamellae formed by
Lan-b-M and Cys-Ala, we can gather that the WAXS pat-
terns reveal the molecular packing of the two-dimensional
crystal that forms the walls of the assemblies. The unit cell
determined from the scattering peaks is a rectangular cell
with the following parameters: a ¼ 16.21 6 0.04 A˚ and b ¼
9.646 0.02 A˚ for Lan-b-M and a¼ 16.116 0.01 A˚ and b¼
9.55 6 0.03 A˚ for Cys-Ala with a ¼ 90 for both peptides
(see Table 2). The distance of 9.55–9.64 A˚ is characteristic of
the repetitive distance of an antiparallel b-sheet (49), which
is in full agreement with the information deduced from the
FTIR spectra. We can thus conclude that the wall of the
observed curved lamellae/nanotubes is built from filaments
formed by head-to-tail and completely interdigitated pep-
tides linked by an antiparallel b-sheet network in the ‘‘b’’
direction and from the lateral packing of these b-sheet fila-
ments in the ‘‘a’’ direction. Table 3 shows a scheme of this
proposed molecular packing of Cys-Ala and Lan-b-M.
The x-ray patterns recorded for the Lys-DLys derivative at
different concentrations are less detailed than those obtained
for the two previous derivatives (Fig. 6 c), although the char-
acteristic Bragg reflections at 0.36 and 1.3 A˚1 are also
detected. Instead of scattering peaks, regular and soft oscilla-
tions are visible on the patterns that can be fitted with a cosine
function with a periodicity of 0.13 A˚1 (45 A˚). Such oscilla-
tions, previously observed in soap films (50), were attributed to
pair interactions between high electron density planes. In our
case, they may be due to either individual layers with rich
TABLE 1 Estimation of the number of backbone carbonyls



















Cys-Ala 10% 5 73 14 87 7 0.998
Lan-b-M 10% 4 73 9 82 7 0.997
This estimation was done on the spectra recorded for the highest concen-
tration of peptide to reduce the contribution of the unstructured spectra arising
from nonassembled peptides. The decomposition was performed using simple
Gaussian curves (see Fig. 2).
FIGURE 3 Electron micrographs obtained from negatively stained sam-
ples of Lan-b-M (5% w/w) show nanotubes shorter (,1 mm) and wider
(100–200 nm) than lanreotide nanotubes.
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electron edges or the stacking of two quasiidentical layers,
which we show as possible molecular packing in Table 3. Cur-
rently, we cannot favor one of these two solutionswithout x-ray
fiber patterns of well-oriented samples. Moreover, none of the
existing models proposed for amyloid fiber organization—
including, the nanotube model proposed by Inouye et al.
(40)—fitted our data. At this time, we can say only that similar
x-ray patternswere reported forb-amyloid fibers (51) and that
this is in agreement with the electronmicroscopy observations.
Aromatic mutants: DNal-DPhe, Tyr-Phe,
and DTrp-D-Phe
For these three derivatives, the FT-Raman spectra exhibit the
same vibration mode around 505–509 cm1, which indicates
that the disulfide bridge adopts a similar g-g-g conformation
to the one adopted in lanreotide. One can also observe the
disappearance of the naphthyl vibration for the DNal-DPhe
derivative and of the tryptophan vibration for the DTrp-DPhe
derivative due to the selective replacement of these side
chains.
The FTIR spectra of the DNal-DPhe and Tyr-Phe deriv-
atives exhibit broad and unresolved FTIR amide I vibrations
(Fig. 7 b, traces 4–8) in the concentration range 5–20%
(w/w). Of these two derivatives, only the Tyr-Phe derivative
at 20% (w/w) exhibits slightly more structured amide I
vibrations (Fig. 7, trace 6).
In the case of the DTrp-DPhe derivative, the FTIR amide I
spectra for three different concentrations (Fig. 7 b, traces
1–3) are very similar to the lanreotide spectra. They exhibit
the four sharp FTIR absorptions at 1618, 1638, 1661, and
1690 cm1 that are characteristic of the b-hairpin conforma-
tion and of the intermolecular antiparallel b-sheet stacking of
lanreotide within the nanotubes (33).
Up to concentrations of 15% (w/w), the DNal-DPhe and
the Tyr-Phe derivatives are soluble in water as clear solutions
(isotropic, optical microscopy), and no gels are formed.
However, in this concentration range SAXS patterns show a
broad diffuse scattering around 0.15A˚1, indicating the for-
mation of aggregates in solution (data not shown). For DNal-
DPhe, the maximum of the diffuse scattering shifts toward
higher angles with increasing peptide concentration. This
indicates a decrease in either the characteristic aggregate size
or the interacting distance between the aggregates detected
by SAXS (from 0.1 to 0.16 A˚1 going from 5% to 30%,
corresponding to a shift from 60 to 40 A˚). At the concen-
tration of 10% (w/w) the Tyr-Phe derivative shows a broad
scattering peak around 0.09 A˚1 (corresponding to a distance
of 70 A˚). Such a broad, diffuse scattering has been observed
for lanreotide at low concentration (concentration below the
critical concentration at which the nanotubes are formed) and/
or at high concentration and high temperature (for temper-
atures at which the nanotubes dissolved), indicating the pres-
ence of aggregates in solution (33), which are probably
intermediates of the assemblies that have not yet been precisely
characterized. The observation of these broad, diffuse scat-
terings may indicate that these derivatives form preaggre-
gates, but since their solubility is much higher than that of
lanreotide they do not, in the concentration range studied
here, undergo self-assembly.
As previously observed, the SAXS patterns obtained for
the DTrp-DPhe derivative from 5% to 20% (w/w) show
FIGURE 4 Electron micrographs ob-
tained either from freeze-fractured (a and
b) or negatively stained (c) samples of
Cys-Ala (5% w/w in water). In a and b,
the arrows indicate either unilamellar
(1 and 19) or multilamellar (2 and 29)
nanotubes
FIGURE 5 Electron micrographs obtained
from negatively stained (a and b) samples of
Lys-DLys (10% w/w in water, acetate) and size
distribution of the width of the fibers observed
(c). The micrographs were taken either just after
the preparation of the sample (a) or after 1 week
(b), showing slow fiber growth. The size distri-
butions were plotted from;200measurements,
indicating an average fiber width of 12 nm.
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regular oscillations, as for lanreotide (34). The fit of the
patterns by a zero order Bessel function indicates that the
DTrp-DPhe derivative in solution forms rigorously mono-
disperse nanotubes 16 nm in diameter. This diameter is in-
dependent of the peptide concentration in the range 5–20%
(w/w). For concentrations higher than 20% (w/w), the mono-
dispersity is lost, as shown by the disappearance of the
oscillations. The SAXS patterns look like those obtained for
lanreotide when embedded nanotubes are formed (33). Like
lanreotide, the DTrp-DPhe nanotubes are packed in a dis-
ordered hexagonal lattice, as shown by the corresponding
broad Bragg reflections in Fig. 8 b. Temperature increase
induces a decrease in the hexagonal parameter (from 260 A˚
at 10C to 235 A˚ at 70C) without any change in nanotube di-
ameter (Fig. 8 c). This behavior is similar to that of lanreotide
solutions. Moreover, all the structural and molecular data
indicate that the molecular and supramolecular packing of
the Trp-Phe derivative is identical to that of lanreotide, as
indicated in Table 3. The only differences between the two
molecular packings within the nanotubes are the number of
filaments n and the unit cell longitudinal shift along these
filament for a complete round of the nanotube. The (n, m)
values are (26, 13) for lanreotide and (18,11) for Trp-Phe
derivative (34).
Freeze-fracture electron micrographs of the DNal-DPhe
derivative show the formation of small ‘‘micelle’’-like ag-
gregates of ;10 nm (Fig. 9), in agreement with the broad
scattering peak in the SAXS data. Moreover, such ‘‘micelle-
like’’ aggregates are very often seen as intermediates in the
formation of amyloid fibers (52–54). For the tyrosine de-
rivative, no aggregate is observed using the freeze-fracture
technique. Then, if some aggregates exist, either their size is
below the resolution of the technique (;3–4 nm) or they are
not fractured during the preparation process.
The freeze-fracture electron micrographs of the DTrp-
DPhe derivative show longitudinal fractures of nanotubes
(Fig. 10). These micrographs show that the nanotubes are
FIGURE 6 WAXS patterns of (a) Lanreotide-b-M, (b) Cys-Ala, and (c)
Lys-DLys derivatives. (a) WAXS patterns of [Lan-b-M acetate] ¼ 9%,
18%, and 30% w/w (traces 1, 2, and 3, respectively). The position (dashed
lines) and the indexing of the Bragg peaks are indicated on the graph. The
indexing is detailed in Table 1. (b) WAXS patterns of Cys-Ala acetate 10%
w/w in water. The position (dashed lines) and the indexing of the Bragg
peaks are indicated on the graph. The indexing is detailed in Table 1. (c)
WAXS patterns of Lys-DLys acetate 10% w/w in water.
TABLE 2 Peak indexations of Lan-b-M and Cys-Ala derivative














0.39 0.39 16,26 (1,0) 0.40 0.39 16.09
0.77 0.77 8,13 (2,0) 0.78 0.78 8.05
– – – (2,1) 1.02 1.02 6.15
1.16 1.16 5,42 (3,0) 1.17 1.17 5.36
1.30 1.30 4,83 (0,2) 1.31 1.32 4.76
1.36 1.36 4,63 (1,2) 1.38 1.38 4.57
1.52 1.51 4,15 (2,2) 1.54 1.53 4.10
The indexation was done with a rectangular lattice. The cell parameters, a
and b, were found to be a ¼ 16.208 6 0.036 A˚ and b ¼ 9.642 6 0.019 A˚
for the Lan-b-M and a ¼ 16.107 6 0.0141 A˚ and b ¼ 9.5526 0.027 A˚ for
Cys-Ala. In the table, the experiment reciprocal spacings (q exp) are com-
pared with those generated with the rectangular lattices (q theo), showing
excellent agreement. The theoretical repetitive distances (d theo) were cal-
culated using d theo ¼ 2p/q theo.
TABLE 3 Self-assembling lanreotide derivatives: self-assembly
morphologies and proposed molecular packing
*Part of the figure has been taken from Aggeli et al. (38) ‘‘copyright
( 2001) National Academy of Sciences, USA’’.
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tightly packed parallel to each other, as expected from the
hexagonal organization of the nanotubes revealed by the
SAXS patterns.
DISCUSSION
Lanreotide, a small peptide of eight amino acids, possesses all
themolecular parameters driving its self-assembly in the pres-
ence of water. The self-assembly process of lanreotide is
controlled by the balance between two opposite forces, i.e.,
hydrophobic effects, which result in water in an ‘‘attraction’’
between peptides and repulsive electrostatic interactions.
Furthermore, the molecular parameters drive the molecular
packing; and to obtain detailed information on these molecular
parameters we adopted a site-directed mutational approach.
We chose either to mutate residues that modify the confor-
mation of the molecule or to successively substitute the three
aromatic residues by a phenylalanine. Besides this precise
purpose, themutationswe chose to apply to lanreotide are also
related to more general questions. The influence of peptide
conformation on molecular packing in self-assembly is, for
example, relevant to amyloid peptides but also to bio-
nanomaterials. In addition, p-stacking has been postulated as
an important type of interaction driving amyloid fibril growth
(3,27,55). Lanreotide and its derivatives are powerful tools in
elucidating the involvement of pp interactions and the
peptide backbone conformation in peptide self-assembling
processes. Moreover, understanding these types of interac-
tions can help to design new molecules capable of forming
desired supramolecular architectures.
FIGURE 7 FT-Raman spectra (a) and ATR-FTIR spec-
tra (b). (a) FT-Raman spectra of DTrp-DPhe acetate 10%
w/w in water (trace 1), Tyr-Phe acetate 15% w/w in water
(trace 2), and DNal-DPhe acetate 10% w/w in water (trace
3). Arrows indicate the position of scattering mode of the
disulfide bridge in a g-g-g conformation (505 cm1) of
naphthalene in the peptides (520 cm1) and of tryptophan
(545–550 cm1). (b) ATR-FTIR spectra of the amide I
vibrations of DTrp-DPhe acetate 5%, 10%, and 15%
(traces 1, 2, and 3, respectively) w/w in water of Tyr-Phe
acetate 5%, 10%, and 20% (traces 4, 5, and 6, respectively)
w/w in water and of DNal-DPhe acetate 5% and 10%
(traces 7 and 8, respectively) w/w in water. Arrows indicate
the positions of the absorption peaks associated with the
carbonyl involved in H-bonds in intermolecular b-sheet
(1625 and 1685 cm1), random coil (1640 cm1), and turn
(1660 cm1) conformations.
FIGURE 8 SAXS patterns of DTrp-
DPhe samples obtained with a sample
to detector distance of 1.5 m (a) and of
6.5 m very small angle x-ray scattering
(b) on ID2 beam line (ESRF, Grenoble)
and change in the hexagonal parameter
with temperature (c). (a) SAXS patterns
as a function of DTrp-DPhe acetate con-
centration (sample to detector distance
of 1.5m). The seven lower patternswere
obtained for 2%, 4%, 5%, 8%, 10%,
15%, and 20% (w/w) of peptide acetate
in water. The dashed curve is a J0 Bessel
function calculated for a radius of 82
nm. The dotted lines i), underline the
minima of the Bessel function that fit
with the experimental ones, and ii),
show that these minima are independent
on peptide concentration. The upper
curve was obtained for 30% (w/w) of
peptide acetate in solution. The arrows
underline the diffuse scattering peaks
induced by the antiparallelb-sheet network. (b) SAXS patterns obtained for 14% (w/w) of peptide acetate in water at 20C (sample to detector distance of 6.5 m).
The dashed lines are in the theoretical position of the Bragg peaks expected for a hexagonal lattice of 259 A˚ to underline that the experimental peak positions are in
agreement with the theoretical ones. (c) Change in the hexagonal lattice parameter with temperature. These data were obtained for 8%, 10%, 14%, and 20% (w/w)
peptide acetate in solution during the heating and cooling process.
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Fig. 11 summarizes the results obtained on the behavior
of the different peptides in water, in terms of assembly,
morphology, and molecular conformation. We schematized
the possible molecular packing that matches our experimental
data. As a general survey, the modifications designed to affect
the conformation of lanreotide, i.e., Lan-b-M andCys-Ala, on
the one hand, and Lys-DLys, on the other, allowed the peptide
to retain its capacity to form supramolecular architectures
involvingb-sheet networks.However, theymodified themor-
phology and the molecular packing of the assemblies more
deeply than lanreotide did. Peptide conformation thus plays a
role in molecular packing within the self-assemblies but does
not affect the self-assembling propensity of the peptides. On
the contrary, slight mutations in the aromatic residues either
considerably decrease the self-assembly capacity of the pep-
tide and its propensity to develop extended b-sheet structures
(DNal-DPhe and Tyr-Phe) or modify only the final diameter
of the nanotubes while keeping the molecular packing
identical to that of lanreotide (DTrp-DPhe) (34). This show
that the three aromatic side chains do not have equivalent roles
in the self-assembly process: the naphthalene and tyrosine
side chains (in the initial lanreotide sequence) play the role
of highly specific molecular ‘‘glue’’ whereas the tryptophan
side chain is involved in the lateral filament stacking.
Which molecular parameters drive self-assembly?
The idea that pp stacking is one of the driving forces of
peptide-protein fiber formation emerged a few years ago. E.
Gazit (56) reviewed studies on peptides extracted from the
sequence of amyloid-forming proteins that kept the self-
assembling properties of the entire protein. All these amino
acid sequences contained a high number of aromatic residues.
Knowing that aromatic residues are among the less frequently
occurring amino acids, this observation is not trivial. More-
over, directedmutations systematically replacing these amino
acids by Ala showed that all but the aromatic amino acids can
be replaced by Ala without changing the propensity for self-
assembly. Indeed, the replacement of the aromatic residues by
Ala completely inhibited this capacity. It was further sug-
gested that pp stacking provides an energetic contribution
as well as order and directionality to the self-assembly of
amyloid structures.
The lanreotide sequence contains three aromatic amino
acids in a total of eight. Besides these hydrophobic aromatic
residues, it has two positive charges, which explain the high
solubility of the peptide since nanotube assembly occurs at
concentrations higher than 30 mM. Among the residues sub-
stituted in this study, we successively mutated the three aro-
matic residues into phenylalanine. We chose to mutate these
aromatic side chains to another aromatic one and not, as Gazit
did (56), to a simple Ala for two major reasons: i), we already
knew from the segregation of the aromatic side chains in the
self-assemblies that these residues played a major role in-
volving pp stacking, and ii), we wanted to know if these
aromatic residues had some specific features. The minimal
mutations DNal-DPhe and Tyr-Phe strongly affect the sol-
ubility of the peptide. Indeed, these two mutants do not form
nanotubes or any other nanoscale self-assemblies based on
extended intermolecular b-sheet, at least in the concentration
range studied in this work, i.e., concentrations up to 10 times
the critical concentration of lanreotide (300 mM). These re-
sults indicate that these mutations together increased the
solubility of the peptide and decreased its self-assembling
propensity. The aromatic interactions in lanreotide nanotubes,
consequently, not only are related to simplepp interactions
but also involve some more specific interactions. For
information, we also tested the mutation of DNal into DAla.
The behavior of this peptide was comparable to that of the
mutant reported in this work (data not shown). From this
study, we conclude that two of the three aromatic residues in
the lanreotide sequence are directly involved in the intermo-
FIGURE 9 Electron micrographs obtained from freeze-fractured solu-
tions of DNal-DPhe acetate 10% w/w in water/glycerol (a) and Tyr-Phe
acetate 10% w/w in water/glycerol (b). Arrows in a underline some of the
‘‘micellar’’-type aggregates. No aggregates were observed in b.
FIGURE 10 Electron micrographs of replicas of freeze-fractured and
etched solution of DTrp-DPhe acetate 10% w/w (a and b) and of negatively
stained solution of DTrp-DPhe acetate 8% w/w in water (c and d).
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lecular peptide-peptide interaction. These results are also in
agreement with the idea developed byC. Dobson that to avoid
protein fiber formation, nature has developed strategies to
increase the solubility of the protein in solution (20). The
presence of aromatic residues that are generally hydrophobic
decreases the solubility of the peptides/proteins. Furthermore,
as they can interact throughpp stacking, these residues can
orient the peptide-peptide interactions. From our data, we
propose that aromatic-aromatic interactions drive such a self-
assembly process. In the case of lanreotide, we propose that
the DNal and the Tyr, due to their capacities through pp
interactions to orientate the self-assembly, represent the
molecular ‘‘glue’’. Moreover, our experiments show that aro-
maticity is not enough. In particular, the behavior of the Tyr-
Phe derivative compared with that of lanreotide raises the
question of the specificity of this aromatic side chain. In recent
preliminary Raman experiments we showed a very unusual
modification of the Tyr environment in relation to its pro-
pensity to form H-bonds within the assemblies (57). Further
experiments are required and have been undertaken to fully
characterize the role of Tyr in the self-assembly process.
However, this new molecular information supports the idea
that at least part of the specificity of Tyr in lanreotide self-
assembly is related to its capacity to act as an H-bound donor
and/or acceptor. Of course, this conclusion does not exclude
the involvement of the electron donor/acceptor properties of
the aromatic cycle in the self-assembly process of lanreotide.
Altogether, these results demonstrate that lanreotide self-
assembly is driven by specific aromatic-aromatic interactions.
What is the relationship between the morphology
of self-assembly and the conformation of
the molecule?
The amino acids of lanreotide have a very particular spatial
distribution relative to the peptide backbone. Lanreotide can
be described as a cyclic peptide, with one face of the cycle
being essentially hydrophilic and the other hydrophobic.
Moreover, the peptide sequence induces a strict segregation
of the aliphatic and aromatic lateral chains pointing to the
hydrophobic face of the cycle. The conformational mutants
generated in this study, besides changing the conformation
of the peptide backbone, modified the distribution of the
hydrophobic and hydrophilic residues relative to the face of
the peptide cyclic backbone.
In terms of amino acid sequence and among the mutations
considered here, the Lys-DLys mutation is the mildest. In-
deed, the sequence is identical to that of lanreotide, the only
change being the configuration of the Lys side chain. From
NMR studies on lanreotide in organic solvents, the monomer
conformation has been characterized as a b-hairpin stabilized
by a disulfide bridge. Moreover, a strong interaction has been
detected between the DTrp and the Lys residues (42) in the
b-turn of the molecule. We have further shown in our pre-
vious work (34) that this b-hairpin conformation is stabilized
for lanreotide in nanotube assemblies.Moreover, the structure
of the nanotubes strongly suggests that the Nal, Tyr, and Val
amino acids point toward the hydrophobic face of the peptide,
whereas the Trp and Lys together point toward the hydro-
philic face. So, in the Lys-DLys mutant, the Lys pointing
toward the hydrophilic face of the wild-type peptide now
points toward the initially hydrophobic face of the backbone,
inducing a drastic decrease in the amphiphilicity of the pep-
tide compared with lanreotide. This modification drastically
affects the molecular packing and consequently the architec-
tures formed. Instead of the well-organized two-dimensional
crystals for lanreotide in the nanotubes, the Lys-DLys de-
rivative self-assembles in a less ordered one-dimensional
amyloid-type liquid crystal. The corresponding x-ray patterns
and electron micrographs are similar to those obtained for
amyloids, observed either for entire prion proteins (51) or for
peptides extracted from prion protein sequences (3). Unfor-
tunately, our structural data are too poor to give the precise
molecular packing of Lys-DLys within the fibers. However,
we can say that they are formed by the lamination of 5–6
layers of peptide filaments, reaching a final average size of
;10–12 nm. Since the hydrophobic and hydrophilic residues
of the peptide are no longer segregated on each face of the
cyclic peptide, the face-to-face dimer cannot be formed. The
peptide-peptide interactions, even if they are still driven by
the aromatic residues, must have a topology that is different
from lanreotide’s. In Table 3, we propose that the Lys-DLys
fibers are formed by a peptide bilayer, with the H-bond net-
work in one direction and the aromatic-aromatic interactions
in the other. The latter interactions can be either located at the
C-terminal (1) and thenmediated by theNaph or located in the
turn (4) and then mediated by the DTrp.
The molecular packing characterized for the opened
lanreotide sequence (either by mutation or by reduction of
the disulfide bridge) can also be explained by a drastic change
in the amphiphilicity of the molecule. In these cases, the hy-
drophobic and hydrophilic residues are distributed along the
linear peptide backbone without any specific topology. The
peptide has the same solubility as lanreotide globally, but
the x-ray data do not show any systematic segregation of the
aromatic residues from the aliphatic ones. These residues are
not orientated with respect to the peptide backbone as they
were for lanreotide. The molecular packing of the lamellar
sheets observed for the Cys-Ala derivative and Lan-b-M are
characterized by the lateral association of filaments, i.e.,
lamination of filaments. These filaments are formed by an anti-
parallel H-bond network between head-to-tail peptides (Table
3), and the interactions between filaments are probably me-
diated by aromatic interactions. Such lamination of amyloid
fibrils forming helical ribbons that further close into large hol-
low cylinders (as we saw for the Lan-b-M) has been observed
for the linear amyloid peptides Ab-(16–22) (58). Interestingly,
these authors proposed that the size of the final fiber depends
on the extent of lamination of the fibrils and that the peptide
size reduction increases the extent of lamination. In the case of
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the Cys-Ala derivative, which forms large nanotubes by fibril
lamination, we are indeed in the same peptide size range as
that for Ab-(16–22). Unlike amyloid peptides, the nanotubes
are formed here by an interdigitated monolayer of the linear
form of lanreotide and not by a bilayer of peptides.
In conclusion, we propose that amphiphilicity drives the
molecular packing, which then drives the morphology, of the
final architectures formed.
How is nanotube diameter modulated?
Lanreotide nanotubes are composed of 26 laterally assem-
bled helicoidal filaments. These filaments are formed by the
stacking of dimer building blocks through two different
antiparallel H-bond networks, i.e., two different protofila-
ments, one external and one internal to the nanotube walls
(34). The contacts between the external and the internal
protofilaments are not equivalent. Indeed, the difference in
periphery for the external and the internal layer is;1/2(2pe)
(e being the thickness of the nanotubes wall), i.e., ;5.6 nm.
This means that the distance between the 26 external and
internal protofilaments differ by 0.22 nm. This value rep-
resents ;10% of the total length of the b-hairpin peptide
(2 nm). In this study, we show that the substitution of the
DTrp (position 4, in the lanreotide turn) by DPhe reduces
the diameter of the nanotubes from 24.4 to 16 nm without
affecting the molecular packing. This particular aromatic
residue is probably not involved in dimer stacking, unlike
DNal (1) and Tyr (3) in the lanreotide sequence, but is likely
involved in the association of the filaments that form the
nanotubes. This also suggests that this particular amino acid
is involved in the close contact between the protofilaments.
The other very important conclusion is that the lanreotide
self-assembly process is rather insensitive to specific prop-
erties of the aromatic side chain in this position, indicating
essentially that pp stacking is involved in the lateral inter-
action between the protofilaments.
CONCLUSIONS
The aim of this studywas to gain information on themolecular
parameters that lead to the remarkable self-assembly process
of lanreotide in water. We demonstrate that the two aromatic
residues DNal (1) and Tyr (3) drive the self-assembly process
by specific aromatic/aromatic interactions that can be electron
and/or H-bond donor/acceptor. Indeed, mutations of these
two aromatic residues drastically decrease the peptide’s pro-
pensity to self-assemble by increasing the solubility of the
peptide and by decreasing the aromatic stacking strength. We
also show that any mutation changing the spatial organization
of the hydrophilic and hydrophobic residues, i.e., the amphi-
pathic pattern of the molecule, modifies the molecular packing
and changes the final supramolecular architecture. We char-
acterize three different molecular packing regimes that lead
to three different morphologies, i.e., i), lamellae formed by an
interdigitatedmonolayer of peptides; ii), nanotubes formedby
face-to-face dimer stacking; and iii), amyloid fibers formed
by the lamination of n-dimensional fibrils (Table 3). These
supramolecular architectures are all stabilized by aromatic
interactions and antiparallel b-sheet networks. Finally, we
show that the aromatic residue located in the b-turn of
lanreotide is involved in the lateral packing of the filaments
and therefore in fixing the final monodisperse diameter of
the nanotubes. Moreover, unlike D-Nal and Tyr, no strong
specificity is observed for the aromatic side chain in position
4, as only pp stacking is involved in this interaction.
The extreme sensitivity of the self-assembly processes of
lanreotide to the molecular sequence of the peptide provides
information that can be related to the molecular parameters
driving amyloid-related self-assemblies. Finally, this work
also describes some of the parameters necessary for the
bottom-up design of new peptide families that self-assemble
into tunable nanotubule or fibril architectures.
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